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The crystal structure of an indomethacin-nicotinamide (1:1) 
co-crystal produced by milling has been determined from 
laboratory powder X-ray diffraction (PXRD) data.  The 
hydrogen-bonding motifs observed in the structure represent 10 
one of the most probable of all the possible combinations of 
donors and acceptors in the constituent molecules. 
Indomethacin (IND ; Fig 1) and nicotinamide (NIC; Fig 1) are 
well-known co-crystal formers,1 and an IND:NIC (1:1) co-crystal 
has been reported and its physicochemical properties 15 
characterised.2  A recent 2D solid-state magic-angle spinning 
NMR study3 has identified a strong Narom···HOOC hydrogen 
bond (H-bond) but the crystal structure has not been reported. 
This communication describes the crystal structure of IND:NIC, 
as solved directly from laboratory-based PXRD data, and a full 20 
H-bonding propensity analysis of the IND and NIC molecules. 
                                        
Fig. 1  The molecular structures of IND (left) and NIC (right). 
A 1:1 molar ratio mixture of IND-MeOH solvate4 and NIC was 
milled in a ball mill for ca. 4 hrs. During the milling process, the 25 
mixture desolvated, leading to co-crystal formation. The resultant 
material was loaded into a 0.7mm borosilicate glass capillary and 
transmission PXRD data collected at room temperature. ‡ The 
diffraction pattern indexed to a monoclinic unit cell of volume 
2343Å3, indicative of a 1:1 IND:NIC co-crystal. A Pawley-type 30 
refinement of the unit cell parameters in space group P21/c was 
carried out using TOPAS,5 yielding a fit with Rwp = 1.236.  The 
crystal structure was then solved using DASH6 and the structure 
refined against the original data using TOPAS. ¶ The final 
refinement included a total of 44 parameters (21 background, 1 35 
scale, 6 torsions, 3 angles, 6 position, 6 orientation and 1 non-H 
ITF), yielding Rwp = 2.912.  
 
The resulting structure was further scrutinised by allowing all 
fractional coordinates to refine freely.  As expected, the reduction 40 
in Rwp to 1.569 came at the expense of some chemical sense 
(mainly H-atom positions), but otherwise the geometry of each of 
the two molecules was well preserved.  The NIC molecules form 
H-bonded chains which interact with the carboxylic acids of 
neighbouring IND molecules via H-bonding of the amide and 45 
Narom functional groups. 
 
Fig. 2  H-bonding scheme in the 1:1 IND:NIC crystal structure. 
In order to place the observed H-bonding interactions in the 
context of the possible interactions that can occur between IND 50 
and NIC, H-bond propensities were calculated7 using the program 
Mercury 3.1.8  Briefly, an H-bond propensity is determined from 
a statistical model built for each donor and acceptor pair.  The 
training dataset for the statistical models is composed of 
molecules extracted from the Cambridge Structural Database9 55 
(CSD) that contain between one and all of the functional groups 
present in the target system.  Variables describing the 
environment of the functional group (e.g. steric density, 
aromaticity and competition) are recorded for each functional 
group along with the presence or absence of an H-bond between 60 
the functional groups.  A logistic regression is applied to the 
training dataset which allows, upon consideration of the 
environmental variables for the functional groups of the target 
molecule(s), predictions in the form of H-bond propensities to be 
determined.  An H-bond propensity for a donor-acceptor pair can 65 
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take a value between 0 and 1, where 0 indicates no likelihood of 
H-bond formation and 1 indicates that an H-bond will always be 
found.  For a co-crystal system, where two components A and B 
are present, an H-bond propensity calculation10 determines the 
likelihood of H-bonding interactions of A with A, B with B and 5 
A with B.  This methodology can be used to direct co-crystal 
screening experiments by providing a quantitative measure of the 
likelihood of an interaction between the two components of the 
system.  Alternatively, it can be used to assess observed co-
crystal structures.  An observed H-bonding pattern composed of 10 
interactions of high propensity is in accord with expectations 
derived from the body of information in the CSD and hence can 
be thought of as favourable.  Conversely an observed H-bond 
pattern that includes unusual outcomes raises an interesting 
question with regard to favourability: might there be other, more 15 
favourable H-bond patterns displayed in polymorphs that are as 
yet undiscovered by screening experiments? 
The functional groups defined for the purpose of the H-bond 
propensity calculation (Fig 3) were taken from the library of 
functional groups provided with the software and the results of 20 
the H-bond propensity calculation performed on the IND:NIC 
system are given in Table 1. 
 
Fig. 3  Functional group definitions for the IND/NIC co-crystal system.  25 
Atom super-script labels, Tx, enumerate the coordination number of the 
specified atoms.  Aromatic bond types are shown with a dashed and solid 
line combination.  The functional groups defined are a) carbonyl (O1), b) 
carboxylic acid (O3, O4), c) methoxy (O2), d) aryl chloride (Cl1), e) 
pyridine (N2) and f) amide (N3, O5).  Note that the bracketed atom 30 
identifiers given in bold correspond with those used in Fig. 2.  The 
combinations of these functional groups are summarised in Table 1 and in 
the ESI. 
It can be seen that the NIC-NIC amide chain is predicted to occur 
with a high propensity, as is the interaction between the NH2 35 
group of the amide and the carboxylic acid group of IND 
(interactions 1 and 3 in Table 1).  The final H-bond interaction 
observed in the crystal structure is the donation of the IND acidic 
proton to the aromatic nitrogen of NIC (interaction 5 in Table 1).  
Interactions 1 and 2 are observed in both polymorphs of 40 
nicotinamide.11  In the IND:NIC crystal structure, donation of the 
NH2 group to the IND carboxylic acid group is predicted to be 
competitive and the acidic proton of IND is able to satisfy the 
pyridine group.  The C=O group of the amide is unlikely to 
accept twice and hence the "weaker" OH donation to the C=O of 45 
the amide (interaction 4; Table 1) does not perturb interaction 1. 
 
Table 1 Summary of the H-bond propensity calculation for the IND:NIC 
co-crystal, including lower (LB) and upper bounds (UB).  The final 
column indicates if the interaction listed is observed in the crystal 50 
structure.  The donor and acceptor groups are shown in Fig. 3. 
 
 
A further result of the H-bond propensity calculation is a chart 
(Fig 4) that displays possible combinations of donors and 55 
acceptors and ranks those combinations on the coordination 
environment of the functional groups (y-axis) and the propensity 
of the interaction (x-axis). § This chart provides a landscape of 
permutations, with donor – acceptor combinations varying from 
less favourable (top left) to more favourable (bottom right). It is 60 
clear that the IND:NIC structure (pink dot) possesses one of the 
best permutations of donors with acceptors.   
 
Fig. 4  A chart showing possible permutations of donors with acceptors 
for the IND:NIC system (blue triangles).  The y axis plots the negative of 65 
the average coordination score whilst the x axis plots the average H-bond 
propensity score for the permutation.  The observed structure is found to 
map onto the permutation highlighted with a pink circle.  Optimal 
outcomes (high propensity score and high coordination score) are found 
in the bottom right of the chart. 70 
Conclusions 
One potential application of H-bond propensity calculations lies 
in the selection of likely co-formers for co-crystals, but it is clear 
from this study that applying such a calculation to a structure 
solved from powder diffraction can provide an informatics-based 75 
piece of evidence to support or oppose the hypothesis that the 
Interaction Donor Acceptor Propensity LB UB  
1 N3 O5 0.71 0.63 0.78  
2 N3 N2 0.70 0.61 0.77   
3 N3 O4 0.67 0.60 0.73  
4 O3 O5 0.59 0.51 0.67   
5 O3 N2 0.57 0.48 0.65  
6 O3 O4 0.54 0.48 0.60   
7 N3 O1 0.48 0.37 0.58   
8 O3 O1 0.35 0.27 0.44   
9 N3 O3 0.15 0.09 0.22   
10 N3 O2 0.13 0.08 0.19   
11 O3 O3 0.09 0.06 0.14   
12 O3 O2 0.08 0.05 0.11   
13 N3 Cl1 0.05 0.03 0.08   
14 O3 Cl1 0.03 0.02 0.05   
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Rietveld refinement global minimum has been correctly located.  
As the complexity of crystal structures solved from powder 
diffraction data increases, so does the likelihood of small 
structural ambiguities that may not be easily resolved from 
consideration of the fit to the diffraction data alone; in such cases, 5 
additional evidence to support a structure from either DFT-type 
calculations,12 H-bond propensity considerations or similarity 
relationships13 is extremely valuable.  In the case of the relatively 
simple IND:NIC co-crystal structure, H-bond propensity 
highlights the fact that the observed H-bonding scheme is one of 10 
several that are predicted to be favourable.  It is possible that 
novel IND:NIC polymorphs could be found that exhibit these 
alternative favourable H-bonding schemes. 
The crystal structure determination reported here was relatively 
straightforward.  For more complex structures, it is possible that 15 
information returned by an 'a priori' H-bond propensity search 
could be incorporated into the crystal structure solution stage, in 
order to increase the probability of locating the global minimum.  
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† Electronic Supplementary Information (ESI) available: Profile fits from 
Rietveld refinement and illustrations of the motifs enumerated in Table 1. 40 
 The International Nonproprietary Name for indomethacin is 
indometacin. 
‡ PXRD data were collected over the range 4–80 2 (2 kW; Cu K1, 
1.54056 Å; step size 0.017 2), using a variable count time scheme. The 
Bruker D8 Advance diffractometer was equipped with a LynxEye 45 
detector.   
¶ The data set was background subtracted and truncated to 38.9 2 for 
Pawley fitting in DASH (2=2.96).  The simulated annealing component 
of DASH was used to optimise the positions, orientations and 
conformations of molecular models of NIC (derived from CSD refcode 50 
GOGQID, with 7 DoF) and IND (derived from CSD refcode INDMET03, 
with 10 DoF) against the diffraction data (194 reflections), yielding a 
favourable 2 of 21.0 for the best solution.  A TOPAS-type rigid-body 
description of this solution was then refined against the original data set 
in the range 4-80 2 to give a good final fit, Rwp= 2.912, Re= 1.153. For 55 
the rigid-body refined fractional coordinates, with errors calculated by the 
bootstrap method, see CCDC reference number 926162. 
§ The propensity score for each possible combination of donors and 
acceptors is calculated from the average of the contributing propensity 
scores.  Similarly the coordination score is the average of the coordination 60 
scores that contribute to the particular permutation of donors and 
acceptors. Coordination scores are calculated using a statistical model 
which captures the likelihood that a functional group participates 0, >1, 
>2 times.   
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